Hyphens Pharma Initiation - Decent Fundamentals, Weak Valuations
We initiate rated coverage on Hyphens with a TP of S$0.365, pegged to 9.5x FY25E P/E, representing an upside of approximately 28.1%.
264 Views
Hyphens Pharma (HYP SP): ASEAN’S Leading Specialty Pharma Company
Hyphens Pharma (HYP SP EQUITY) is Singapore’s leading specialty pharmaceutical and consumer healthcare group, leveraging on its diverse footprints...
303 Views
Thomson Medical (TMG SP)/Tmc Life Sciences (TMCL MK): Strong Recovery; Scale Expansion to Aid Growth
Thomson Medical, with predominant focus on gynecology and pediatrics, is well-positioned to benefit from Singapore and Malaysia re-opening. Recent...
510 Views
The Week That Was in ASEAN@Smartkarma - Alfamart's Guidance, Indonesia's Pragmatism, and Thai Banks
The past week saw insights on Sumber Alfaria Trijaya (AMRT IJ, SLB Development (SLB SP), Japfa Ltd (JAP SP), Hyphens Pharma International (HYP SP),...
580 Views
Unveiling Potential Gems Within the Catalist
The Evolve Capital team is excited to begin its foray into equity research, with the ability to offer a more diverse set of offerings alongside our...
285 Views